Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Gene Therapeutics & RNAi

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1791860

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1791860

Gene Synthesis (Research Use)

PUBLISHED:
PAGES: 565 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Gene Synthesis (Research Use) Market to Reach US$4.5 Billion by 2030

The global market for Gene Synthesis (Research Use) estimated at US$2.1 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Solid-Phase Synthesis, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Chip-based Synthesis segment is estimated at 15.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$559.3 Million While China is Forecast to Grow at 18.5% CAGR

The Gene Synthesis (Research Use) market in the U.S. is estimated at US$559.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$953.4 Million by the year 2030 trailing a CAGR of 18.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.4% and 12.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.

Global Gene Synthesis (Research Use) Market - Key Trends & Drivers Summarized

Why Is Gene Synthesis Transforming Research in Genetic Engineering?

Gene synthesis has become an indispensable tool in modern molecular biology, enabling researchers to create custom DNA sequences with high precision and efficiency. Unlike traditional cloning techniques that rely on existing genetic material, gene synthesis allows scientists to design and construct novel genes from scratch, facilitating breakthroughs in synthetic biology, genetic engineering, and biomedical research. This capability has revolutionized studies in gene function, protein engineering, and drug discovery, making gene synthesis a critical resource for research institutions, pharmaceutical companies, and biotech firms.

Advancements in DNA assembly technologies, such as enzymatic synthesis and chip-based DNA printing, have significantly reduced synthesis costs while increasing speed and accuracy. Automated gene synthesis platforms now allow for the rapid generation of long and complex DNA sequences, enabling large-scale genomic studies and high-throughput screening. The increasing adoption of gene synthesis in CRISPR research, vaccine development, and metabolic pathway engineering has further accelerated its demand. As scientists continue to explore new frontiers in genomics and personalized medicine, gene synthesis is poised to play a crucial role in unlocking the full potential of synthetic biology.

Which Research Fields Are Driving the Demand for Gene Synthesis?

Gene synthesis is widely utilized across multiple scientific disciplines, each benefiting from its ability to precisely manipulate genetic sequences. In synthetic biology, researchers use gene synthesis to design and optimize biological systems, enabling the production of biofuels, specialty chemicals, and engineered microbes for industrial applications. The pharmaceutical industry relies on synthesized genes for antibody development, protein expression studies, and vaccine production, particularly in mRNA-based vaccine research.

Agricultural biotechnology is another major sector leveraging gene synthesis for crop improvement and pest resistance studies. Scientists are engineering plant genomes to enhance drought tolerance, nutrient content, and yield performance, providing sustainable solutions to global food security challenges. Additionally, gene synthesis plays a vital role in virology and epidemiology, where researchers construct viral genomes to study pathogen evolution and develop targeted antiviral therapies. The growing demand for precision genetics in these fields continues to fuel the expansion of the gene synthesis market, making it an essential tool for cutting-edge scientific research.

What Are the Latest Technological Advancements in Gene Synthesis?

Technological advancements in gene synthesis have significantly improved the accuracy, efficiency, and scalability of DNA synthesis processes. One of the most groundbreaking innovations is enzymatic DNA synthesis, which eliminates the need for traditional phosphoramidite chemistry, reducing chemical waste and increasing synthesis speed. This approach has enabled the development of cost-effective and environmentally friendly gene synthesis methods, making DNA fabrication more accessible to researchers worldwide.

Additionally, the integration of artificial intelligence (AI) and machine learning in gene design and optimization has enhanced sequence assembly, reducing error rates and improving functional gene expression. AI-driven algorithms can predict secondary structures, codon biases, and regulatory elements, ensuring optimal gene performance in experimental systems. The use of microfluidic platforms and high-throughput DNA synthesis techniques has also accelerated the production of large DNA libraries for applications such as protein engineering and directed evolution. These technological advancements are revolutionizing gene synthesis, enabling scientists to push the boundaries of genetic research with unprecedented precision.

What Factors Are Fueling the Growth of the Gene Synthesis Market?

The growth in the gene synthesis market is driven by several factors, including increasing demand for synthetic biology applications, advancements in DNA synthesis technology, and expanding research in genetic engineering. The pharmaceutical and biotechnology sectors are investing heavily in synthetic gene constructs for drug discovery, antibody engineering, and vaccine development, contributing to market expansion. Additionally, government funding for genomics research and synthetic biology initiatives has further propelled demand for gene synthesis services.

The growing need for customized genetic constructs in agricultural biotechnology, industrial microbiology, and metabolic engineering has also boosted market adoption. The rise of cloud-based bioinformatics platforms and AI-driven gene design tools has made gene synthesis more efficient and cost-effective, allowing researchers to accelerate discovery and innovation. Furthermore, the increasing use of gene synthesis in personalized medicine and gene therapy research is expected to drive long-term market growth. As the field of synthetic biology continues to evolve, gene synthesis will remain a fundamental technology shaping the future of genetic research and biotechnological advancements.

SCOPE OF STUDY:

The report analyzes the Gene Synthesis (Research Use) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Method (Solid-Phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis); Service (Antibody DNA Synthesis Service, Viral DNA Synthesis Service, Other Services); Research Phase (Pre-Clinical Research Phase, Clinical Research Phase); Application (Gene & Cell Therapy Development Application, Vaccine Development Application, Other Applications); End-Use (Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use, Contract Research Organizations End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • ATUM (formerly DNA2.0)
  • BaseClear
  • Bio Basic Inc.
  • BioCat GmbH
  • Biomatik
  • Bioneer Corporation
  • Boster Biological Technology
  • DNA Script
  • Eurofins Genomics
  • GENEWIZ (Azenta Life Sciences)
  • Geneworks Pty Ltd.
  • GenScript
  • Integrated DNA Technologies
  • Macrogen
  • OriGene Technologies
  • ProteoGenix
  • Sangon Biotech
  • Synbio Technologies
  • Thermo Fisher Scientific
  • Twist Bioscience

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP31160

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Gene Synthesis (Research Use) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Boom in Synthetic Biology and Custom Gene Engineering Drives Growth of the Gene Synthesis Market
    • Growing Demand for Customized DNA Constructs in R&D Accelerates Adoption of Gene Synthesis Services
    • Expansion of CRISPR and Genome Editing Research Fuels Demand for High-Fidelity, Error-Free Gene Constructs
    • Wider Use of Synthetic Genes in Vaccine Development, Antibody Production, and Metabolic Engineering Broadens Market Scope
    • Decreasing Cost of DNA Synthesis Technologies Enhances Accessibility for Academic and Commercial Labs
    • Integration of Gene Synthesis with Cloning and Expression Services Drives Bundled Offerings by CROs and Biotech Firms
    • Rising Use of Gene Synthesis in Agriculture, Industrial Biotech, and Environmental Applications Creates Non-Therapeutic Demand
    • OEM Advancements in High-Throughput and Automated Gene Synthesis Platforms Reduce Turnaround Times
    • Expansion of Startups in Synthetic Biology Fuels Contract-Based Outsourcing of Gene Design and Synthesis
    • Increased Demand for Complex Constructs Including Promoters, Plasmids, and Multi-Gene Pathways Boosts Technical Complexity
    • Regulatory Considerations for Biosecurity and Sequence Screening Prompt Increased Compliance Infrastructure
    • OEM Collaboration with Biofoundries and Genetic Engineering Labs Accelerates Innovation in Scalable Synthesis
    • Cloud-Based Gene Design Tools and Ordering Platforms Simplify Workflow for Academic Researchers
    • Use of AI and Machine Learning in Sequence Optimization Improves Yield and Functional Expression of Synthesized Genes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gene Synthesis (Research Use) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gene Synthesis (Research Use) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gene Synthesis (Research Use) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Solid-Phase Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Solid-Phase Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Solid-Phase Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chip-based Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chip-based Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chip-based Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for PCR-based Enzyme Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for PCR-based Enzyme Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for PCR-based Enzyme Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vaccine Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vaccine Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Vaccine Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Gene & Cell Therapy Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Gene & Cell Therapy Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Gene & Cell Therapy Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biotechnology & Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Biotechnology & Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Biotechnology & Pharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Academic & Government Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Academic & Government Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Academic & Government Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Antibody DNA Synthesis Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Antibody DNA Synthesis Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Antibody DNA Synthesis Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Viral DNA Synthesis Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Viral DNA Synthesis Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Viral DNA Synthesis Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Pre-Clinical Research Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Pre-Clinical Research Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Pre-Clinical Research Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Clinical Research Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Clinical Research Phase by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Clinical Research Phase by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Canada 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • JAPAN
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 77: Japan Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Japan Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Japan 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Japan 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Japan 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • CHINA
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 92: China Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: China 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: China 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: China 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • EUROPE
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Gene Synthesis (Research Use) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Gene Synthesis (Research Use) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Europe 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Europe 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Europe 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Europe 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Europe 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • FRANCE
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 125: France Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: France 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: France 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 131: France Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: France Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: France 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 134: France Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: France 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: France 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • GERMANY
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Germany 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 143: Germany Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Germany Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Germany 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 146: Germany Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Germany Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Germany 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Germany 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Germany 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 155: Italy Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Italy Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Italy 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 158: Italy Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Italy Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Italy 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 161: Italy Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Italy Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Italy 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Italy 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 167: Italy Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Italy Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Italy 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 170: UK Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: UK Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: UK 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 173: UK Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: UK Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: UK 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 176: UK Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: UK Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: UK 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 179: UK Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: UK Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: UK 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 182: UK Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: UK Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: UK 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 185: Spain Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Spain Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Spain 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 188: Spain Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Spain Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Spain 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 191: Spain Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Spain Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Spain 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 194: Spain Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Spain Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Spain 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 197: Spain Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Spain Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Spain 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 200: Russia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Russia Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Russia 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 203: Russia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Russia Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Russia 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 206: Russia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Russia Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Russia 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 209: Russia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Russia Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Russia 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 212: Russia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Russia Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Russia 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 215: Rest of Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Europe Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Europe 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 218: Rest of Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Europe Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Rest of Europe 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 221: Rest of Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Rest of Europe Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Rest of Europe 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Europe Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Europe 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Europe Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Europe 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 230: Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 231: Asia-Pacific Historic Review for Gene Synthesis (Research Use) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 233: Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Asia-Pacific Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 236: Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Asia-Pacific Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 239: Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Asia-Pacific Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Asia-Pacific Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Asia-Pacific Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 248: Australia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Australia Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Australia 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 251: Australia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Australia Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Australia 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 254: Australia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Australia Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Australia 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 257: Australia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Australia Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Australia 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 260: Australia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Australia Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Australia 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • INDIA
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 263: India Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: India Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: India 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 266: India Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: India Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: India 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 269: India Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: India Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: India 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 272: India Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: India Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: India 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 275: India Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: India Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: India 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 278: South Korea Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: South Korea Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: South Korea 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 281: South Korea Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: South Korea Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: South Korea 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 284: South Korea Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: South Korea Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: South Korea 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 287: South Korea Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: South Korea Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: South Korea 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 290: South Korea Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: South Korea Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: South Korea 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 293: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Asia-Pacific Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Asia-Pacific Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Asia-Pacific Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Asia-Pacific Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Asia-Pacific Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Asia-Pacific 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 308: Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 309: Latin America Historic Review for Gene Synthesis (Research Use) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Latin America 15-Year Perspective for Gene Synthesis (Research Use) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 311: Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Latin America Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Latin America 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 314: Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Latin America Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Latin America 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 317: Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Latin America Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Latin America 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 320: Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Latin America Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Latin America 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 323: Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Latin America Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Latin America 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 326: Argentina Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Argentina Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Argentina 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 329: Argentina Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Argentina Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Argentina 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 332: Argentina Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Argentina Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Argentina 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 335: Argentina Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Argentina Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Argentina 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 338: Argentina Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Argentina Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Argentina 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 341: Brazil Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Brazil Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Brazil 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 344: Brazil Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Brazil Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Brazil 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 347: Brazil Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Brazil Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Brazil 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 350: Brazil Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Brazil Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Brazil 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 353: Brazil Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Brazil Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Brazil 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 356: Mexico Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Mexico Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Mexico 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 359: Mexico Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Mexico Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Mexico 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 362: Mexico Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Mexico Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Mexico 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 365: Mexico Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Mexico Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Mexico 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 368: Mexico Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Mexico Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: Mexico 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 371: Rest of Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Latin America Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Latin America 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Latin America Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Latin America 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Latin America Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Latin America 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Latin America Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Latin America 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 383: Rest of Latin America Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Latin America Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: Rest of Latin America 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 386: Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 387: Middle East Historic Review for Gene Synthesis (Research Use) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: Middle East 15-Year Perspective for Gene Synthesis (Research Use) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 389: Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Middle East Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: Middle East 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 392: Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Middle East Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Middle East 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 395: Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Middle East Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Middle East 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 398: Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Middle East Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: Middle East 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 401: Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Middle East Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: Middle East 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 404: Iran Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Iran Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 406: Iran 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 407: Iran Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Iran Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 409: Iran 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 410: Iran Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Iran Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 412: Iran 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 413: Iran Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Iran Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 415: Iran 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 416: Iran Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Iran Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 418: Iran 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 419: Israel Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Israel Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 421: Israel 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 422: Israel Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Israel Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 424: Israel 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 425: Israel Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 426: Israel Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 427: Israel 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 428: Israel Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 429: Israel Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 430: Israel 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 431: Israel Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 432: Israel Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 433: Israel 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 434: Saudi Arabia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 435: Saudi Arabia Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 436: Saudi Arabia 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 437: Saudi Arabia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 438: Saudi Arabia Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 439: Saudi Arabia 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 440: Saudi Arabia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 441: Saudi Arabia Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 442: Saudi Arabia 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 443: Saudi Arabia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 444: Saudi Arabia Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 445: Saudi Arabia 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 446: Saudi Arabia Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 447: Saudi Arabia Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 448: Saudi Arabia 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 449: UAE Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 450: UAE Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 451: UAE 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 452: UAE Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 453: UAE Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 454: UAE 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 455: UAE Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 456: UAE Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 457: UAE 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 458: UAE Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 459: UAE Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 460: UAE 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 461: UAE Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 462: UAE Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 463: UAE 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 464: Rest of Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 465: Rest of Middle East Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 466: Rest of Middle East 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 467: Rest of Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 468: Rest of Middle East Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 469: Rest of Middle East 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 470: Rest of Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 471: Rest of Middle East Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 472: Rest of Middle East 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 473: Rest of Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 474: Rest of Middle East Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 475: Rest of Middle East 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 476: Rest of Middle East Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 477: Rest of Middle East Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 478: Rest of Middle East 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030
  • AFRICA
    • Gene Synthesis (Research Use) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 479: Africa Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 480: Africa Historic Review for Gene Synthesis (Research Use) by Method - Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 481: Africa 15-Year Perspective for Gene Synthesis (Research Use) by Method - Percentage Breakdown of Value Sales for Solid-Phase Synthesis, Chip-based Synthesis and PCR-based Enzyme Synthesis for the Years 2015, 2025 & 2030
    • TABLE 482: Africa Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 483: Africa Historic Review for Gene Synthesis (Research Use) by Application - Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 484: Africa 15-Year Perspective for Gene Synthesis (Research Use) by Application - Percentage Breakdown of Value Sales for Vaccine Development Application, Other Applications and Gene & Cell Therapy Development Application for the Years 2015, 2025 & 2030
    • TABLE 485: Africa Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 486: Africa Historic Review for Gene Synthesis (Research Use) by End-Use - Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 487: Africa 15-Year Perspective for Gene Synthesis (Research Use) by End-Use - Percentage Breakdown of Value Sales for Biotechnology & Pharmaceutical Companies End-Use, Academic & Government Research Institutes End-Use and Contract Research Organizations End-Use for the Years 2015, 2025 & 2030
    • TABLE 488: Africa Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 489: Africa Historic Review for Gene Synthesis (Research Use) by Service - Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 490: Africa 15-Year Perspective for Gene Synthesis (Research Use) by Service - Percentage Breakdown of Value Sales for Antibody DNA Synthesis Service, Viral DNA Synthesis Service and Other Services for the Years 2015, 2025 & 2030
    • TABLE 491: Africa Recent Past, Current & Future Analysis for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 492: Africa Historic Review for Gene Synthesis (Research Use) by Research Phase - Pre-Clinical Research Phase and Clinical Research Phase Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 493: Africa 15-Year Perspective for Gene Synthesis (Research Use) by Research Phase - Percentage Breakdown of Value Sales for Pre-Clinical Research Phase and Clinical Research Phase for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!